Invion ( (AU:IVX) ) has issued an announcement.
Invion Limited has requested a trading halt on its securities on the Australian Securities Exchange pending an announcement regarding a capital raising initiative. This move is intended to help the company manage its continuous disclosure obligations, with the trading halt expected to last until the announcement is made or normal trading resumes on March 4, 2025. The outcome of this announcement could have significant implications for Invion’s financial strategy and market positioning.
More about Invion
Invion Limited operates in the biotechnology industry, focusing on the development of treatments for chronic inflammatory diseases. The company is listed on the Australian Securities Exchange (ASX) under the ticker IVX.
Average Trading Volume: 110
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $6.43M
See more insights into IVX stock on TipRanks’ Stock Analysis page.